UPDATE: H.C. Wainwright Starts Foghorn Therapeutics (FHTX) at Buy

November 22, 2021 6:10 AM EST Send to a Friend
(Updated - November 22, 2021 6:30 AM EST)

H.C. Wainwright analyst Andrew Fein initiates coverage on Foghorn Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login